Related Experiment Video
Updated: Sep 29, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomavirus type 16 E6 induces cell competition
Nicole Brimer1, Scott Vande Pol1
1Department of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
High-risk human papillomavirus (HPV) E6 protein drives cell competition, enabling infected cells to displace normal cells. This finding reveals a new role for E6 in tumor development beyond traditional oncogenicity.
Area of Science:
- Oncology
- Virology
- Cell Biology
Background:
- High-risk human papillomavirus (HPV) infections are linked to squamous epithelial tumors.
- HPV-infected cells initially expand at the expense of uninfected cells, but the mechanisms are not fully understood.
Purpose of the Study:
- To investigate the role of specific HPV16 oncoproteins in cell competition.
- To elucidate the mechanism by which HPV-infected cells displace normal keratinocytes.
Main Methods:
- Developed an in vitro assay using HPV16-expressing keratinocytes and uninfected keratinocytes.
- Assessed the contribution of HPV16 E6, E5, and E7 oncoproteins to cell competition.
- Investigated the interaction between E6 and p53.
Main Results:
- HPV16 E6 expression alone, not E5 or E7, conferred enhanced colony competition.
- E6-expressing keratinocytes displaced adjacent normal keratinocytes by undermining their substrate contact.
- E6 interaction with p53 was required for this cell competition.
Conclusions:
- HPV16 E6 oncoprotein is primarily responsible for cell competition, distinct from E7's role in oncogenicity.
- This study identifies a novel biological function for high-risk HPV E6 oncoproteins in promoting tumor development through cell competition.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Mitogens and the Cell Cycle
Induced Pluripotent Stem Cells
Somatic...
Mechanisms of Retrovirus-induced Cancers

